▶ 調査レポート

敗血症診断の世界市場 2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Sepsis Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。敗血症診断の世界市場 2020年:企業別、地域別、種類・用途別 / Global Sepsis Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D005-00886資料のイメージです。• レポートコード:D005-00886
• 出版社/出版日:GlobalInfoResearch / 2020年5月29日
• レポート形態:英文、PDF、125ページ
• 納品方法:Eメール
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥365,400 (USD3,480)▷ お問い合わせ
  Multi User¥548,100 (USD5,220)▷ お問い合わせ
  Corporate User¥730,800 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、敗血症診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。敗血症診断の種類別市場規模(微生物学、分子診断学、イムノアッセイ、フローサイトメトリー、マイクロフルイディクス、バイオマーカー)、用途別市場規模(病院、病理・リファレンス研究所)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Biomerieux、Bruker、Becton, Dickinson、T2 Biosystems、Thermo Fisher、Luminex、Immunexpress、Danaher、Roche、Abbott、EKF Diagnostics、Response Biomedical、Mitsubishi Chemical、Axis-Shield Diagnostics、Cytosorbents
・地域別グローバル市場分析 2015年-2020年
・敗血症診断の北米市場(アメリカ、カナダ、メキシコ)
・敗血症診断のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・敗血症診断のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・敗血症診断の南米市場(ブラジル、アルゼンチン)
・敗血症診断の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:微生物学、分子診断学、イムノアッセイ、フローサイトメトリー、マイクロフルイディクス、バイオマーカー
・用途別分析:病院、病理・リファレンス研究所
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Sepsis Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.9% in the forecast period of 2020 to 2025 and will expected to reach USD 439.3 million by 2025, from USD 362.3 million in 2019.

The Sepsis Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Sepsis Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Sepsis Diagnostics market has been segmented into:
Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Microfluidics
Biomarkers

By Application, Sepsis Diagnostics has been segmented into:
Hospitals
Pathology & Reference Laboratories

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sepsis Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Sepsis Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sepsis Diagnostics market.

The report offers in-depth assessment of the growth and other aspects of the Sepsis Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Sepsis Diagnostics Market Share Analysis
Sepsis Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sepsis Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sepsis Diagnostics sales, revenue and market share for each player covered in this report.

The major players covered in Sepsis Diagnostics are:
Biomerieux
Bruker
Becton, Dickinson
T2 Biosystems
Thermo Fisher
Luminex
Immunexpress
Danaher
Roche
Abbott
EKF Diagnostics
Response Biomedical
Mitsubishi Chemical
Axis-Shield Diagnostics
Cytosorbents

レポート目次

Table of Contents

1 Sepsis Diagnostics Market Overview
1.1 Product Overview and Scope of Sepsis Diagnostics
1.2 Classification of Sepsis Diagnostics by Type
1.2.1 Global Sepsis Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sepsis Diagnostics Revenue Market Share by Type in 2019
1.2.3 Microbiology
1.2.4 Molecular Diagnostics
1.2.5 Immunoassays
1.2.6 Flow Cytometry
1.2.7 Microfluidics
1.2.8 Biomarkers
1.3 Global Sepsis Diagnostics Market by Application
1.3.1 Overview: Global Sepsis Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Pathology & Reference Laboratories
1.4 Global Sepsis Diagnostics Market by Regions
1.4.1 Global Sepsis Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sepsis Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sepsis Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sepsis Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sepsis Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sepsis Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sepsis Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Biomerieux
2.1.1 Biomerieux Details
2.1.2 Biomerieux Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biomerieux SWOT Analysis
2.1.4 Biomerieux Product and Services
2.1.5 Biomerieux Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bruker
2.2.1 Bruker Details
2.2.2 Bruker Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bruker SWOT Analysis
2.2.4 Bruker Product and Services
2.2.5 Bruker Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Becton, Dickinson
2.3.1 Becton, Dickinson Details
2.3.2 Becton, Dickinson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Becton, Dickinson SWOT Analysis
2.3.4 Becton, Dickinson Product and Services
2.3.5 Becton, Dickinson Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 T2 Biosystems
2.4.1 T2 Biosystems Details
2.4.2 T2 Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 T2 Biosystems SWOT Analysis
2.4.4 T2 Biosystems Product and Services
2.4.5 T2 Biosystems Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Thermo Fisher
2.5.1 Thermo Fisher Details
2.5.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Thermo Fisher SWOT Analysis
2.5.4 Thermo Fisher Product and Services
2.5.5 Thermo Fisher Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Luminex
2.6.1 Luminex Details
2.6.2 Luminex Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Luminex SWOT Analysis
2.6.4 Luminex Product and Services
2.6.5 Luminex Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Immunexpress
2.7.1 Immunexpress Details
2.7.2 Immunexpress Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Immunexpress SWOT Analysis
2.7.4 Immunexpress Product and Services
2.7.5 Immunexpress Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Danaher SWOT Analysis
2.8.4 Danaher Product and Services
2.8.5 Danaher Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Roche
2.9.1 Roche Details
2.9.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Roche SWOT Analysis
2.9.4 Roche Product and Services
2.9.5 Roche Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.10 Abbott
2.10.1 Abbott Details
2.10.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Abbott SWOT Analysis
2.10.4 Abbott Product and Services
2.10.5 Abbott Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.11 EKF Diagnostics
2.11.1 EKF Diagnostics Details
2.11.2 EKF Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 EKF Diagnostics SWOT Analysis
2.11.4 EKF Diagnostics Product and Services
2.11.5 EKF Diagnostics Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.12 Response Biomedical
2.12.1 Response Biomedical Details
2.12.2 Response Biomedical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Response Biomedical SWOT Analysis
2.12.4 Response Biomedical Product and Services
2.12.5 Response Biomedical Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.13 Mitsubishi Chemical
2.13.1 Mitsubishi Chemical Details
2.13.2 Mitsubishi Chemical Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Mitsubishi Chemical SWOT Analysis
2.13.4 Mitsubishi Chemical Product and Services
2.13.5 Mitsubishi Chemical Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.14 Axis-Shield Diagnostics
2.14.1 Axis-Shield Diagnostics Details
2.14.2 Axis-Shield Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Axis-Shield Diagnostics SWOT Analysis
2.14.4 Axis-Shield Diagnostics Product and Services
2.14.5 Axis-Shield Diagnostics Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.15 Cytosorbents
2.15.1 Cytosorbents Details
2.15.2 Cytosorbents Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Cytosorbents SWOT Analysis
2.15.4 Cytosorbents Product and Services
2.15.5 Cytosorbents Sepsis Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sepsis Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sepsis Diagnostics Players Market Share
3.2.2 Top 10 Sepsis Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sepsis Diagnostics Revenue and Market Share by Regions
4.2 North America Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Sepsis Diagnostics Revenue by Countries
5.1 North America Sepsis Diagnostics Revenue by Countries (2015-2020)
5.2 USA Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Sepsis Diagnostics Revenue by Countries
6.1 Europe Sepsis Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sepsis Diagnostics Revenue by Countries
7.1 Asia-Pacific Sepsis Diagnostics Revenue by Countries (2015-2020)
7.2 China Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Sepsis Diagnostics Revenue by Countries
8.1 South America Sepsis Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sepsis Diagnostics by Countries
9.1 Middle East & Africa Sepsis Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sepsis Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Sepsis Diagnostics Market Forecast by Type (2019-2024)
10.3 Microbiology Revenue Growth Rate (2015-2025)
10.4 Molecular Diagnostics Revenue Growth Rate (2015-2025)
10.5 Immunoassays Revenue Growth Rate (2015-2025)
10.6 Flow Cytometry Revenue Growth Rate (2015-2025)
10.7 Microfluidics Revenue Growth Rate (2015-2025)
10.8 Biomarkers Revenue Growth Rate (2015-2025)
11 Global Sepsis Diagnostics Market Segment by Application
11.1 Global Sepsis Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Sepsis Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Pathology & Reference Laboratories Revenue Growth (2015-2020)
12 Global Sepsis Diagnostics Market Size Forecast (2021-2025)
12.1 Global Sepsis Diagnostics Market Size Forecast (2021-2025)
12.2 Global Sepsis Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Sepsis Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Sepsis Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sepsis Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Sepsis Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sepsis Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Sepsis Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sepsis Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sepsis Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sepsis Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Biomerieux Corporate Information, Location and Competitors
Table 6. Biomerieux Sepsis Diagnostics Major Business
Table 7. Biomerieux Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Biomerieux SWOT Analysis
Table 9. Biomerieux Sepsis Diagnostics Product and Solutions
Table 10. Biomerieux Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bruker Corporate Information, Location and Competitors
Table 12. Bruker Sepsis Diagnostics Major Business
Table 13. Bruker Sepsis Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Bruker SWOT Analysis
Table 15. Bruker Sepsis Diagnostics Product and Solutions
Table 16. Bruker Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Becton, Dickinson Corporate Information, Location and Competitors
Table 18. Becton, Dickinson Sepsis Diagnostics Major Business
Table 19. Becton, Dickinson Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. Becton, Dickinson SWOT Analysis
Table 21. Becton, Dickinson Sepsis Diagnostics Product and Solutions
Table 22. Becton, Dickinson Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. T2 Biosystems Corporate Information, Location and Competitors
Table 24. T2 Biosystems Sepsis Diagnostics Major Business
Table 25. T2 Biosystems Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. T2 Biosystems SWOT Analysis
Table 27. T2 Biosystems Sepsis Diagnostics Product and Solutions
Table 28. T2 Biosystems Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Thermo Fisher Corporate Information, Location and Competitors
Table 30. Thermo Fisher Sepsis Diagnostics Major Business
Table 31. Thermo Fisher Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Thermo Fisher SWOT Analysis
Table 33. Thermo Fisher Sepsis Diagnostics Product and Solutions
Table 34. Thermo Fisher Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Luminex Corporate Information, Location and Competitors
Table 36. Luminex Sepsis Diagnostics Major Business
Table 37. Luminex Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Luminex SWOT Analysis
Table 39. Luminex Sepsis Diagnostics Product and Solutions
Table 40. Luminex Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Immunexpress Corporate Information, Location and Competitors
Table 42. Immunexpress Sepsis Diagnostics Major Business
Table 43. Immunexpress Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Immunexpress SWOT Analysis
Table 45. Immunexpress Sepsis Diagnostics Product and Solutions
Table 46. Immunexpress Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Danaher Corporate Information, Location and Competitors
Table 48. Danaher Sepsis Diagnostics Major Business
Table 49. Danaher Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Danaher SWOT Analysis
Table 51. Danaher Sepsis Diagnostics Product and Solutions
Table 52. Danaher Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Roche Corporate Information, Location and Competitors
Table 54. Roche Sepsis Diagnostics Major Business
Table 55. Roche Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Roche SWOT Analysis
Table 57. Roche Sepsis Diagnostics Product and Solutions
Table 58. Roche Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Abbott Corporate Information, Location and Competitors
Table 60. Abbott Sepsis Diagnostics Major Business
Table 61. Abbott Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 62. Abbott SWOT Analysis
Table 63. Abbott Sepsis Diagnostics Product and Solutions
Table 64. Abbott Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. EKF Diagnostics Corporate Information, Location and Competitors
Table 66. EKF Diagnostics Sepsis Diagnostics Major Business
Table 67. EKF Diagnostics Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 68. EKF Diagnostics SWOT Analysis
Table 69. EKF Diagnostics Sepsis Diagnostics Product and Solutions
Table 70. EKF Diagnostics Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Response Biomedical Corporate Information, Location and Competitors
Table 72. Response Biomedical Sepsis Diagnostics Major Business
Table 73. Response Biomedical Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 74. Response Biomedical SWOT Analysis
Table 75. Response Biomedical Sepsis Diagnostics Product and Solutions
Table 76. Response Biomedical Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Mitsubishi Chemical Corporate Information, Location and Competitors
Table 78. Mitsubishi Chemical Sepsis Diagnostics Major Business
Table 79. Mitsubishi Chemical Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 80. Mitsubishi Chemical SWOT Analysis
Table 81. Mitsubishi Chemical Sepsis Diagnostics Product and Solutions
Table 82. Mitsubishi Chemical Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Axis-Shield Diagnostics Corporate Information, Location and Competitors
Table 84. Axis-Shield Diagnostics Sepsis Diagnostics Major Business
Table 85. Axis-Shield Diagnostics Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 86. Axis-Shield Diagnostics SWOT Analysis
Table 87. Axis-Shield Diagnostics Sepsis Diagnostics Product and Solutions
Table 88. Axis-Shield Diagnostics Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Cytosorbents Corporate Information, Location and Competitors
Table 90. Cytosorbents Sepsis Diagnostics Major Business
Table 91. Cytosorbents Sepsis Diagnostics Total Revenue (USD Million) (2017-2018)
Table 92. Cytosorbents SWOT Analysis
Table 93. Cytosorbents Sepsis Diagnostics Product and Solutions
Table 94. Cytosorbents Sepsis Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Sepsis Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 96. Global Sepsis Diagnostics Revenue Share by Players (2015-2020)
Table 97. Global Sepsis Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Sepsis Diagnostics Revenue Market Share by Regions (2015-2020)
Table 99. North America Sepsis Diagnostics Revenue by Countries (2015-2020)
Table 100. North America Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Table 101. Europe Sepsis Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Sepsis Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Sepsis Diagnostics Revenue by Countries (2015-2020)
Table 104. South America Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Sepsis Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Table 107. Global Sepsis Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 108. Global Sepsis Diagnostics Revenue Share by Type (2015-2020)
Table 109. Global Sepsis Diagnostics Revenue Forecast by Type (2021-2025)
Table 110. Global Sepsis Diagnostics Revenue by Application (2015-2020)
Table 111. Global Sepsis Diagnostics Revenue Share by Application (2015-2020)
Table 112. Global Sepsis Diagnostics Revenue Forecast by Application (2021-2025)
Table 113. Global Sepsis Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sepsis Diagnostics Picture
Figure 2. Global Sepsis Diagnostics Revenue Market Share by Type in 2019
Figure 3. Microbiology Picture
Figure 4. Molecular Diagnostics Picture
Figure 5. Immunoassays Picture
Figure 6. Flow Cytometry Picture
Figure 7. Microfluidics Picture
Figure 8. Biomarkers Picture
Figure 9. Sepsis Diagnostics Revenue Market Share by Application in 2019
Figure 10. Hospitals Picture
Figure 11. Pathology & Reference Laboratories Picture
Figure 12. Global Sepsis Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Sepsis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Sepsis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Sepsis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Sepsis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Sepsis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Sepsis Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Sepsis Diagnostics Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Sepsis Diagnostics Revenue Market Share in 2019
Figure 21. Global Top 10 Players Sepsis Diagnostics Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Sepsis Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Sepsis Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 25. Global Sepsis Diagnostics Revenue Market Share by Regions in 2018
Figure 26. North America Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Europe Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. South America Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 31. North America Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 32. North America Sepsis Diagnostics Revenue Market Share by Countries in 2019
Figure 33. USA Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Canada Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 36. Europe Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Sepsis Diagnostics Revenue Market Share by Countries in 2019
Figure 38. Germany Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. UK Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. France Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Russia Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Italy Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Sepsis Diagnostics Revenue Market Share by Countries in 2019
Figure 45. China Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Japan Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Korea Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. India Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 50. South America Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 51. South America Sepsis Diagnostics Revenue Market Share by Countries in 2019
Figure 52. Brazil Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Sepsis Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Sepsis Diagnostics Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. UAE Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Sepsis Diagnostics Revenue and Growth Rate (2015-2020)
Figure 60. Global Sepsis Diagnostics Revenue Share by Type (2015-2020)
Figure 61. Global Sepsis Diagnostics Revenue Share by Type in 2019
Figure 62. Global Sepsis Diagnostics Market Share Forecast by Type (2021-2025)
Figure 63. Global Microbiology Revenue Growth Rate (2015-2020)
Figure 64. Global Molecular Diagnostics Revenue Growth Rate (2015-2020)
Figure 65. Global Immunoassays Revenue Growth Rate (2015-2020)
Figure 66. Global Flow Cytometry Revenue Growth Rate (2015-2020)
Figure 67. Global Microfluidics Revenue Growth Rate (2015-2020)
Figure 68. Global Biomarkers Revenue Growth Rate (2015-2020)
Figure 69. Global Sepsis Diagnostics Revenue Share by Application (2015-2020)
Figure 70. Global Sepsis Diagnostics Revenue Share by Application in 2019
Figure 71. Global Sepsis Diagnostics Market Share Forecast by Application (2021-2025)
Figure 72. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 73. Global Pathology & Reference Laboratories Revenue Growth Rate (2015-2020)
Figure 74. Global Sepsis Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Sepsis Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Sepsis Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Sepsis Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Europe Sepsis Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Sepsis Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. South America Sepsis Diagnostics Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Sepsis Diagnostics Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel